RecruitingPhase 3NCT07088068
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Sponsor: Sanofi
Asheville, NC · Chapel Hill, NC · +32 more sites
2 recruiting type 1 diabetes studies with a site in Asheville, NC.
Sponsor: Sanofi
Asheville, NC · Chapel Hill, NC · +32 more sites
Sponsor: SAb Biotherapeutics, Inc.
Asheville, NC · Chapel Hill, NC · +20 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.